France · Series A startup

Who invested in DiogenX

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$37Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $37MMay 2023
Investors
3
See who backed them

The rounds

  1. May 2023

Founders and team

From DiogenX's own website: 3 founders, 4 on the team.

Benjamin CharlesCEO, co-founder, member of the Board
Jean-Pascal TraniéCo-Founder
Patrick CollombatPhD, co-founder
  • Glyn ParkinIndependant Chairman of the Board
  • Joanna FaresDirector Drug Development Sciences
  • Manuel BaaderInvestment Manager
  • Renaud PerretDirector Finance & Administration

Everyone who backed them

OmnesVC firm1round
Eli LillyCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DiogenX

Who invested in DiogenX?

DiogenX's investors include Omnes, Eli Lilly and Boehringer Ingelheim Venture Fund.

How much has DiogenX raised?

DiogenX has raised $37M across 1 round since 2023.

When did DiogenX last raise?

DiogenX's most recent round was a Series A of $37M in May 2023.

What was DiogenX's biggest round?

Its most recent round, $37M in May 2023, is also its largest on record.

Who backed DiogenX first?

DiogenX's first round on record, in May 2023, was backed by Omnes, Eli Lilly and Boehringer Ingelheim Venture Fund.

What stage is DiogenX at?

DiogenX's latest named round is a Series A, in May 2023.

Where is DiogenX based?

DiogenX is based in France.

Companies like DiogenX

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.